POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in...

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Mutations in the POT1 gene are linked to abnormally long telomeres and increased cancer risk, including cardiac angiosarcomas (CAS).
• The precise mechanisms connecting long telomeres to tumorigenesis remain unclear.

Purpose of the Study:

• To investigate the somatic genetic landscape of angiosarcoma patients with POT1 mutations.
• To explore the genetic basis of CAS in patients lacking POT1 mutations.
• To understand the link between POT1 dysfunction, DNA damage signaling, and tumor development.

Main Methods:

• Somatic mutation profiling of 3 angiosarcoma patients with POT1 mutations.
• Genetic analysis of 7 CAS patients without POT1 mutations.
• Assessment of ATR-dependent DNA damage signaling, cell cycle arrest, and apoptosis.

Main Results:

• CAS patients with nonfunctional POT1 exhibited unrepressed ATR signaling, increased cell cycle arrest, and activating mutations in the VEGF/angiogenesis pathway (KDR).
• Similar patterns were observed in POT1 mutation carriers with non-CAS tumors and in CAS patients with mutations in other DNA damage-related genes.
• POT1 inhibition and DNA damage response malfunction promote cell cycle arrest and interfere with apoptosis.

Conclusions:

• Impaired POT1 function or DNA damage response leads to sustained DNA damage signaling, cell cycle arrest, and apoptosis defects.
• These cellular dysregulations permit the accumulation of somatic mutations in the VEGF/angiogenesis pathway, driving tumor formation.
• Targeting DNA damage signaling in POT1 mutation carriers could potentially prevent tumor development by correcting cell cycle and apoptosis abnormalities.